The Chicago Entrepreneur

Moderna’s Covid vaccine for teens awaits OK as regulators review heart inflammation risk

Moderna applied for emergency approval of its Covid vaccine for 12- to 17-year-olds in June, but the FDA said its review wouldn’t be completed before January.

Editorial Team

Previous post Ford shares fall after fourth-quarter earnings significantly miss Wall Street’s expectations
Next post ‘I didn’t want to wait any longer.’ Meet three entrepreneurs who quit during the ‘Great Resignation’ to start their own businesses